Joseph Michael Fitzgerald Boston Scientific Corp (BSX) insider trading activity

Joseph Michael Fitzgerald is EVP & Group Pres, Cardiology of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 178,342 shares of BSX, which is worth approximately $18.3 Million. The most recent transaction as insider was on Oct 01, 2025, when has been sold 50,000 shares (Common Stock) at a price of $98.65 per share, resulting in proceeds of $4,932,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 178K

0% 3M change

11.14% 12M change

Total Value Held $18.3 Million

Joseph Michael Fitzgerald Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 01 2025	SELL Open market or private sale	$4,932,500 $98.65 p/Share	50,000 Reduced 21.9%	178,342 Common Stock
Oct 01 2025	BUY Exercise of conversion of derivative security	$1,307,500 $26.15 p/Share	50,000 Added 17.96%	228,342 Common Stock
Sep 02 2025	SELL Open market or private sale	$5,268,500 $105.37 p/Share	50,000 Reduced 21.9%	178,342 Common Stock
Sep 02 2025	BUY Exercise of conversion of derivative security	$1,307,500 $26.15 p/Share	50,000 Added 17.96%	228,342 Common Stock
Aug 01 2025	SELL Open market or private sale	$5,231,500 $104.63 p/Share	50,000 Reduced 21.9%	178,342 Common Stock
Aug 01 2025	BUY Exercise of conversion of derivative security	$1,307,500 $26.15 p/Share	50,000 Added 17.96%	228,342 Common Stock
Jul 01 2025	SELL Open market or private sale	$5,348,500 $106.97 p/Share	50,000 Reduced 21.9%	178,342 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	$1,307,500 $26.15 p/Share	50,000 Added 17.96%	228,342 Common Stock
Jun 04 2025	SELL Open market or private sale	$5,799,551 $102.88 p/Share	56,372 Reduced 24.02%	178,342 Common Stock
Jun 04 2025	BUY Exercise of conversion of derivative security	$1,474,127 $26.15 p/Share	56,372 Added 19.37%	234,714 Common Stock
Feb 25 2025	SELL Bona fide gift	-	340 Reduced 0.19%	178,342 Common Stock
Feb 24 2025	SELL Bona fide gift	-	1,700 Reduced 0.94%	178,682 Common Stock
Feb 20 2025	SELL Bona fide gift	-	1,000 Reduced 0.55%	180,382 Common Stock
Feb 17 2025	SELL Payment of exercise price or tax liability	$218,268 $106.11 p/Share	2,057 Reduced 1.12%	181,382 Common Stock
Feb 17 2025	BUY Exercise of conversion of derivative security	-	4,167 Added 2.22%	183,439 Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$191,634 $106.11 p/Share	1,806 Reduced 1.0%	179,272 Common Stock
Feb 16 2025	BUY Exercise of conversion of derivative security	-	3,960 Added 2.14%	181,078 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$211,158 $106.11 p/Share	1,990 Reduced 1.11%	177,118 Common Stock
Feb 14 2025	BUY Exercise of conversion of derivative security	-	4,362 Added 2.38%	179,108 Common Stock
Feb 12 2025	SELL Payment of exercise price or tax liability	$167,010 $105.77 p/Share	1,579 Reduced 0.9%	174,746 Common Stock
Feb 12 2025	BUY Exercise of conversion of derivative security	-	3,462 Added 1.93%	176,325 Common Stock
Feb 11 2025	SELL Payment of exercise price or tax liability	$1,531,093 $105.98 p/Share	14,447 Reduced 7.71%	172,863 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	31,680 Added 14.47%	187,310 Common Stock
Jan 01 2025	SELL Payment of exercise price or tax liability	$573,881 $89.32 p/Share	6,425 Reduced 3.97%	155,600 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	13,907 Added 7.9%	162,025 Common Stock

JMF

Joseph Michael Fitzgerald

EVP & Group Pres, Cardiology

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account